Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Data_Sheet_1_rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels.docx by Munal B. Kandel (18526539)

“…This study tested the hypothesis that novel JDNI8 replication-defective herpes simplex-1 viral vectors (rdHSV) carrying a CA8 transgene (vHCA8) reduce primary afferent neuronal excitability. …”

Validated registry of pre-dialysis chronic kidney disease: description of a large cohort by Rosalia Maria Nunes Henriques Huaira (5187425)

Validated registry of pre-dialysis chronic kidney disease: description of a large cohort by Rosalia Maria Nunes Henriques Huaira (5187425)

Table_1_Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes... by Jie Chen (5892)

“…After three months post-SIIT, DPP-4 activity remained stable in the remission group (39.63 ± 8.53 nmol/L) but increased in the non-remission group (42.34 ± 6.64 nmol/L). This resulted in a more pronounced decrease in DPP-4 activity from baseline in the remission group (-3.39 ± 8.90 vs. -1.10 ± 8.95, P = 0.035). …”

Transitioning of people with T1D from Multiple Daily Injections (MDI) and Self-Monitoring of Blood Glucose (BGM) directly to MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system... by Bartłomiej Matejko (13180606)

“…</p> <p>Results: 41 participants were recruited and randomized to either the AHCL (20) or the MDI+BGM (21) group. 37 participants (age 40.3±8.0 years; duration of diabetes 17.3 ± 12.1 years; BMI 25.1±3.1 kg/m2; HbA1c 7.2% ± 1.0) completed the study. Time spent in target (TIR) increased from 69.3±12.3% at baseline to 85.0±6.3% at 3 months in the AHCL group, while remaining unchanged in the control group: treatment effect 21.5% [95% CI 15.7, 27.3%]; p < 0.001. …”

After the injection of PAM, the level of PPARγ increases, and the expression of TGFβ1/SMAD3 decreases, thereby inhibiting EMT and improving intestinal fibrosis. (A) Changes in the mRNA expression level of E-cadherin. (B) Changes in the mRNA expression level of N-cadherin. (C) Changes in the mRNA expression level of V-cadherin. (D) Changes in the mRNA expression level of COL1A1.... by Yi You (2567890)

“…(C) Changes in the mRNA expression level of V-cadherin. (D) Changes in the mRNA expression level of COL1A1. …”

IL-1Ra ASO treatment in HFD-fed obese mice results in decreased body weight (A) despite similar food intake (B) (food intake measured weekly and presented as average food intake ov... by Niclas Franck (632562)

Supplementary Material for: Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and In... by Li Q. (2850350)

Mitochondrial transport was reduced in A53T α-syn axons. by Li Li (14993)

“…<b>G</b>, Percentage of mobile mitochondria significantly decreased in A53T (~8%) compared to that in wt neurons (>30%). …”

Flow diagram of participant selection. by Prajwal Paudel (7359209)

“…Lack of exposure to ACS was associated with higher odds of prolonged hospital stay (aOR: 3.321, 95% CI: 1.957–5.638) and mortality (aOR: 5.731, 95% CI: 3.199–10.266).…”

Supplementary file ACS. by Prajwal Paudel (7359209)

“…Lack of exposure to ACS was associated with higher odds of prolonged hospital stay (aOR: 3.321, 95% CI: 1.957–5.638) and mortality (aOR: 5.731, 95% CI: 3.199–10.266).…”

Decreasing <i>VCP</i> function increases the activation of the Ire1/Xbp1 UPR pathway in <i>Rh1^P37H</i>-expressing flies. by Ana Griciuc (243073)

Temporal dynamics of Sox10-E1 and Sox10-E2 along the OL lineage. by Hongjoo An (21703199)

Involvement of COX-2/PGE2 signaling in proliferation of A549 cells. by Erina Takai (465811)

“…Each value represents the mean ± SE (n = 5-7) (C) Treatment with AH6809 (30 µM), L798106 (30 µM) or L161982 (30 µM) for 3 days suppressed proliferation of A549 cells. …”

pGenesil-siSurvivin and pGenesil-shiHBV4 have synergistic effects in decreasing the survivin protein level and inducing apoptosis of HepG2.2.15 cells. by Jingwei Ma (125700)